Picture of Shanghai Junshi Biosciences Co logo

1877 Shanghai Junshi Biosciences Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Shanghai Junshi Biosciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-795-1,256-1,452-1,463-1,459
Other Operating Cash Flow
Cash from Operating Activities-1,456-605-1,776-2,005-1,434
Capital Expenditures-580-902-394-833-691
Purchase of Fixed Assets
Other Investing Cash Flow Items-160-1,016-43.3-101-202
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-740-1,918-437-933-893
Financing Cash Flow Items4,4842,9763,906254-35.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities4,4142,6664,6137121,023
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,1711202,492-2,219-1,291